With regard to the special qualities of human breast milk and milk production, nurses should be aware that:

Choice A rationale

Congenital dermal melanocytosis, previously called Mongolian spots, are benign, flat, slate-grey, or bluish-green dermal melanocytic lesions typically found on the sacrum, buttocks, or lower back of newborns, more common in Asian, Black, or Hispanic infants. They result from melanocytes being trapped deep in the dermis during their migration from the neural crest to the epidermis, where they are usually found, causing the distinct color due to the Tyndall effect. They generally fade spontaneously within the first few years of life.

Choice B rationale

Nevus flammeus, commonly known as a port-wine stain, is a capillary malformation resulting from a localized defect in the formation of dermal capillaries, leading to a permanent dilation of post-capillary venules. This birthmark appears as a flat, pink, red, or purple patch on the skin, often unilaterally, and does not fade with time; it may even darken and thicken. It is not characterized by the bluish-green markings on the buttocks described.

Choice C rationale

Vascular nevi is a general term encompassing various birthmarks arising from abnormal blood vessel development, including hemangiomas and vascular malformations like nevus flammeus. Hemangiomas are typically raised, bright red, or deep blue/purple tumors of proliferating endothelial cells, often appearing days or weeks after birth, unlike the described flat marks. This term is too non-specific for the precise description.

Choice D rationale

Lanugo is the term for the fine, soft, downy hair that covers the body of a fetus, beginning around the fourth or fifth month of gestation. It is often still present on the newborn, especially premature infants, but it is hair, not a skin marking or lesion. Its function is believed to be related to temperature regulation and adherence of the vernix caseosa; it is shed within the first few weeks of life. —.

Choice A rationale

Vitamin K (phytonadione) is essential for the hepatic synthesis of clotting factors II, VII, IX, and X. Newborns are born with a sterile gut; the bacterial colonization necessary to produce adequate vitamin K is not established for several days, leading to a temporary, normal deficiency, hence the prophylactic injection.

Choice B rationale

While maternal diet plays a role, the primary reason for newborn deficiency is poor placental transfer of vitamin K and the lack of gut flora at birth, not solely maternal deficiency. The standard dosage of 0.5 to 1.0 mg intramuscularly is given to prevent Vitamin K Deficiency Bleeding (VKDB).

Choice C rationale

Vitamin K does not prevent the synthesis of prothrombin (Factor II); rather, it is a co-factor for the enzyme that activates or carboxylates these clotting factors, making them functional for the coagulation cascade. Its administration promotes normal clotting factors.

Choice D rationale

The initial supply of vitamin K is inadequate because the gastrointestinal tract of the newborn is not yet colonized with the bacteria required for its synthesis. This leads to a peak risk of bleeding around 2 to 5 days of life, which is addressed by a single prophylactic dose at birth. —. .